Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Features of systemic lupus erythematosus in Dnase1-deficient mice

Abstract

Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease that affects over one million people in the United States. SLE is characterized by the presence of anti-nuclear antibodies (ANA) directed against naked DNA and entire nucleosomes. It is thought that the resulting immune complexes accumulate in vessel walls, glomeruli and joints and cause a hypersensitivity reaction type III, which manifests as glomerulonephritis, arthritis and general vasculitis. The aetiology of SLE is unknown, but several studies suggest that increased liberation or disturbed clearance of nuclear DNA-protein complexes after cell death may initiate and propagate the disease1,2,3,4,5,6. Consequently, Dnase1, which is the major nuclease present in serum, urine and secreta, may be responsible for the removal of DNA from nuclear antigens at sites of high cell turnover and thus for the prevention of SLE (refs 711). To test this hypothesis, we have generated Dnase1-deficient mice by gene targeting. We report here that these animals show the classical symptoms of SLE, namely the presence of ANA, the deposition of immune complexes in glomeruli and full-blown glomerulonephritis in a Dnase1-dose-dependent manner. Moreover, in agreement with earlier reports10, we found Dnase1 activities in serum to be lower in SLE patients than in normal subjects. Our findings suggest that lack or reduction of Dnase1 is a critical factor in the initiation of human SLE.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Deletion of Dnase1 (ref. 12) by gene targeting.
Figure 2: ANA in Dnase1-deficient mice.
Figure 3: Immune-complex nephritis in Dnase1-deficient mice.
Figure 4: DNASE1 activity in sera of patients with nephropathic diseases.

Similar content being viewed by others

References

  1. Carroll, M.C. The lupus paradox. Nature Genet. 19, 3– 4 (1998).

    Article  CAS  Google Scholar 

  2. Vanholder, R., De Keyser, F., Kips, J., Praet, M. & Naeyaert, J.M. The pathophysiology of lupus erythematosus. Eur. J. Dermatol. 1, 4–7 (1998).

    Google Scholar 

  3. Berden, J.H.M., Licht, R., Van Bruggen, M.C.J. & Tax, W.J.M. Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curr. Opin. Nephrol. Hypertens. 8, 299–306 (1999).

    Article  CAS  Google Scholar 

  4. Rosen, A. & Casciola-Rosen, L. Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 6, 6– 12 (1999).

    Article  CAS  Google Scholar 

  5. Eilat, D. & Naparstek, Y. Anti-DNA autoantibodies: a puzzle of autoimmune phenomena. Immunol. Today 20, 339–342 (1999).

    Article  CAS  Google Scholar 

  6. Lachmann, P.J. An attempt to characterize the lupus erythematosus cell antigen. Immunology 4, 153–163 ( 1961).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Lacks, S.A. Deoxyribonuclease I in mammalian tissues. J. Biol. Chem. 256, 2644–2648 (1981).

    CAS  PubMed  Google Scholar 

  8. Takeshita, H. et al. Mouse deoxyribonuclease I (Dnase I): biochemical and immunological characterization, cDNA structure and tissue distribution. Biochem. Mol. Biol. Int. 42, 65–75 (1997).

    CAS  PubMed  Google Scholar 

  9. Peitsch, M.C., Polzar, B., Tschopp, J. & Mannherz, H.G. About the involvement of deoxyribonuclease I in apoptosis. Cell Death Differ. 1, 1–6 (1994).

    CAS  PubMed  Google Scholar 

  10. Chitrabamrung, S., Rubin, R.L. & Tan, E.M. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol. Int. 1, 55–60 (1981).

    Article  CAS  Google Scholar 

  11. Macanovic, M. & Lachmann, P.J. Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay. Clin. Exp. Immunol. 108, 220–226 ( 1997).

    Article  CAS  Google Scholar 

  12. Peitsch, M.C., Irmler, M., French, L.E. & Tschopp, J. Genomic organisation and expression of mouse deoxyribonuclease I. Biochem. Biophys. Res. Commun. 207, 62–68 (1995).

    Article  CAS  Google Scholar 

  13. Shimoda, M. et al. Anti-DNA IgA autoantibodies are spontaneously generated in mouse Peyer's patches. Immunology 95, 200 –207 (1998).

    Article  CAS  Google Scholar 

  14. Polzar, B. et al. Distribution of deoxyribonuclease I in rat tissues and its correlation to cellular turnover and apoptosis (programmed cell death). Eur. J. Cell Biol. 64, 200–210 (1994).

    CAS  PubMed  Google Scholar 

  15. Rumore, P.M. & Steinman, C.R. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J. Clin. Invest. 86, 69– 74 (1990).

    Article  CAS  Google Scholar 

  16. Macanovic, M. et al. The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone. Clin. Exp. Immunol. 106, 243–252 (1996).

    Article  CAS  Google Scholar 

  17. Verthelyi, D., Dybdal, N., Elias, K.A. & Klinman, D.M. DNAse treatment does not improve the survival of lupus prone (NZB/NZW) F1 mice . Lupus 7, 223–230 (1998).

    Article  CAS  Google Scholar 

  18. Botto, M. et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Genet. 19, 56–59 (1998).

    Article  CAS  Google Scholar 

  19. Bickerstaff, M.C.M. et al. Serum amyloid P component controls chromatin degradation and prevents anti-nuclear autoimmunity. Nature Med. 5, 694–697 (1999).

    Article  CAS  Google Scholar 

  20. Davis, J.C. et al. Recombinant human Dnase I (rhDNase) in patients with lupus nephritis. Lupus 8, 68– 76 (1999).

    Article  Google Scholar 

  21. Nadano, D., Yasuda, T. & Kishi, K. Measurement of deoxyribonuclease 1 activity in human tissues and body fluids by a single radial enzyme-diffusion method. Clin. Chem. 39, 448–452 ( 1993)

    CAS  PubMed  Google Scholar 

  22. Elkon, K.B., Parnassa, A.P. & Foster, C.L. Lupus autoantibodies target ribosomal P proteins. J. Exp. Med. 162, 459–471 (1985).

    Article  CAS  Google Scholar 

  23. Moore, T.L., Weiss, T.D., Neucks, S.H., Baldassare, A.R. & Zuckner, J. Extractable nuclear antigens. Semin. Arthritis Rheum. 10, 309–318 (1981).

    Article  CAS  Google Scholar 

  24. Polzar, B. & Mannherz, H.G. Nucleotide sequence of a full length cDNA clone encoding the deoxyribonuclease I from the rat parotid gland . Nucleic Acids Res. 18, 7151 (1990).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank B. Polzar for rat Dnase1 cDNA; P. Ferrier for the pPNT vector; E. Gau, E.-M. Konieczny, K. Klar, T. Klöckl and S. Wulf for technical assistance; and W. Zidek and M. Tepel for patient sera. This work was supported by a grant of the Fond der Chemischen Industrie to T.M.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tarik Möröy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Napirei, M., Karsunky, H., Zevnik, B. et al. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25, 177–181 (2000). https://doi.org/10.1038/76032

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/76032

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing